The Current Ratio as of December 2025 (TTM) for Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) is 4.60

According to Wuhan Hiteck Biological Pharma Co.,Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 4.60. This represents a change of 3.08% compared to the average of 4.46 of the last 4 quarters.

Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) Historical Current Ratio (quarterly & annually)

How has 300683.SZ Current Ratio performed in the past?

The mean historical Current Ratio of Wuhan Hiteck Biological Pharma Co.,Ltd over the last ten years is 4.27. The current 4.60 Current Ratio has changed 10.66% with respect to the historical average. Over the past ten years (40 quarters), 300683.SZ's Current Ratio was at its highest in in the September 2021 quarter at 10.31. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Wuhan Hiteck Biological Pharma Co.,Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) Average Current Ratio

How has 300683.SZ Current Ratio performed in the past?

The current Current Ratio of Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) Current Ratio vs. Peers

How is 300683.SZ’s Current Ratio compared to its peers?

Wuhan Hiteck Biological Pharma Co.,Ltd’s Current Ratio is greater than Harbin Medisan Pharmaceutical Co., Ltd. (0.97), greater than Jinhe Biotechnology Co. Ltd. (0.94), greater than Yabao Pharmaceutical Group Co., Ltd (3.14), greater than Honz Pharmaceutical Co., Ltd. (0.67), greater than LanZhou Foci Pharmaceutical Co.,Ltd. (3.10), greater than Tibet Weixinkang Medicine Co., Ltd. (4.07), greater than Zhejiang Starry Pharmaceutical Co.,Ltd. (0.89), greater than Zhuhai Rundu Pharmaceutical Co., Ltd. (1.60), greater than ZhuZhou QianJin Pharmaceutical Co.,Ltd (1.40), greater than Tianjin Tianyao Pharmaceuticals Co., Ltd. (1.74),

Build a custom stock screener for Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Wuhan Hiteck Biological Pharma Co.,Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Wuhan Hiteck Biological Pharma Co.,Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.